Epidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy.

Epidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy.

Item
http://www.wikidata.org/entity/Q44740671
ErbB polymorphisms: insights and implications for response to targeted cancer therapeuticsAllele Frequencies of the Epidermal Growth Factor Receptors Polymorphism R521K in Colorectal Cancer Patients and Healthy Subjects Indicate a Risk-Reducing Effect of K521 in Syrian PopulationA Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.Association among polymorphisms in EGFR gene exons, lifestyle and risk of gastric cancer with gender differences in Chinese Han subjects.Simul-seq: combined DNA and RNA sequencing for whole-genome and transcriptome profiling.PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response.Tyrosine kinase domain mutations of EGFR gene in head and neck squamous cell carcinoma.Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis.A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer.EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy.FcγR and EGFR polymorphisms as predictive markers of cetuximab efficacy in metastatic colorectal cancer.Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecan.Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.Identification of novel markers for 5-FU and FOLFOX toxicity.Association between EGFR gene polymorphisms, skin rash and response to anti-EGFR therapy in metastatic colorectal cancer patients.EGFR ligands and DNA repair genes: genomic predictors of complete response after capecitabine-based chemoradiotherapy in locally advanced rectal cancer.Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC).
P2860

Epidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy.

Item
http://www.wikidata.org/entity/Q44740671
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Epidermal growth factor recept ...... cetuximab-based chemotherapy.
@en
Epidermal growth factor recept ...... cetuximab-based chemotherapy.
@nl
type
label
Epidermal growth factor recept ...... cetuximab-based chemotherapy.
@en
Epidermal growth factor recept ...... cetuximab-based chemotherapy.
@nl
prefLabel
Epidermal growth factor recept ...... cetuximab-based chemotherapy.
@en
Epidermal growth factor recept ...... cetuximab-based chemotherapy.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Epidermal growth factor recept ...... cetuximab-based chemotherapy.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1349-7006.2012.02225.X
P433
P478
P577
P5875
P698
P921